A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk, according to an interim safety review.
- About
- Projects
- Library
- Bibliography of Bioethics
- Bioethics News
- For Students
- Contacts
- NBNPM
- Advanced Certificate Program
Papildomos nuorodos
